The AI 100 in numbers.

Humanoid robots data bible. 

The future of AI agents.

 

View in browser

June 28, 2025

Hi there,

 

Here are this week's top research briefs.

ICYMI

 

Here’s how the 100 most promising AI startups in 2025 compare by the numbers

In April, we identified 100 of the most promising emerging AI companies — here’s how they stack up against each other.

Screenshot 2025-06-27 at 12.11.06 PM-1

Book of Scouting Reports: Humanoid Robots

We dive into the data on the most promising private humanoid companies, including key financial metrics, opportunities, and threats.

Screenshot 2025-06-27 at 11.51.29 AM

Battle of the Cloud Titans: How Amazon, Microsoft, and Alphabet are preparing for an AI future

The top 3 global cloud providers are racing to monetize the AI boom. Drawing on CB Insights' Business Graph — which links data across private investments, acquisitions, business relationships, and public company disclosures — we surface key signals on how each cloud player is capitalizing on this technological revolution to expand their market shares.

AI-sparks-cloud-growth-1024x1024

Y Combinator’s 2025 Spring batch reveals the future of agentic AI

We analyze Y Combinator's Spring 2025 batch to uncover the top trends in agentic AI, spanning workflow automation, software development, and applications in highly regulated industries.

YCombinatorMM-062025-2

Customer-Exclusive Research

 

The humanoid robots market map

We mapped out 60+ companies developing humanoid robots for applications across manufacturing, logistics, healthcare, home assistance, and more.

Screenshot 2025-06-27 at 12.04.46 PM
Enterprise AI agents & copilots: Our growth projections for the $5B+ market

With valuations, funding rounds, and revenue moving at breakneck speeds, sizing up the market for enterprise AI agents & copilots can be challenging. Mining CB insights data reveals a market worth billions — and one poised for exponential growth.

AI-Agents-Market-Size-Projections-2025

Inside Novo Nordisk’s $33B manufacturing push to strengthen its obesity portfolio and build a biologics powerhouse

We mined Novo Nordisk’s acquisitions, investments, and partnerships to discern its strategic priorities and future plans.

Screenshot 2025-06-27 at 12.08.22 PM

Have a great weekend.

 

I love you. 

 

 Anand

@asanwal

Co-Founder & Exec Chair

 

P.S. Love exploring cutting-edge technology? Join our team as an Emerging Tech Research Associate — apply here.

Get started with CB Insights

Start your free trial

CB Insights' emerging technology insights platform provides all the analysis and data from this newsletter. Our data is the easiest way to discover and respond to emerging tech. 

Was this email forwarded to you? Sign up here

X
LinkedIn
CB-Insights-Icon-Light

Copyright © 2025 CB Insights, All rights reserved.

498 7th Avenue, NY, CB Insights, New York,10018

About Us | Update Preferences | Research | Newsletter